EG ·
SPASMOFREE 50 MG 20 TAB
SPASMOFREE 50 MG 20 TAB
Composition
These source-reported data require scientific review and are not treatment advice.
CEFDINIR
· AMOUNT_PER_UNIT
TIEMONIUM METHYLSULPHATE
· AMOUNT_PER_UNIT
Registration
Packages and prices
SPASMOFREE 50 MG 20 TABLETS
Explainable alternatives
Candidates are informational and are not automatic authorization for substitution or dispensing.
| Product | Match | Differences | Price |
|---|---|---|---|
| SPASMOFREE 50 MG 25 STRIP | EXACT_PHARMACEUTICAL_COMPOSITION | — | — EGP |
| OMNICEF 300 MG 10 CAP | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, dosage_form | — EGP |
| SPASMOFREE 10MG/5ML SYRUP 120ML | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, dosage_form | — EGP |
| dinar 10 cap | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, dosage_form | — EGP |
| VISCERA 5MG/2ML 3/AMP | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, dosage_form, route | — EGP |
| DINAR 125MG SUSP. 100ML | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, dosage_form, route | — EGP |
| CEFDIN 125mg SUSP 60ML | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, dosage_form, route | — EGP |
| MAXIDINIR 250MG 60 ML SUSP | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, dosage_form, route | — EGP |
| MAXIDINIR 125MG 60 ML SUSP | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, dosage_form, route | — EGP |
| EGYNIR 125 MG 60 ML SUSP | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, dosage_form, route | — EGP |
| spasmofree 50mg 10 tab | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis | — EGP |
| viscera 50 mg tab | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis | — EGP |